Memorial Sloan Kettering Cancer Center

A generous donor saved her life — and today, she’s saving others as a @MSKCancerCenter nurse. Lauren Kidd was diagnosed with cancer as a teen, and the only chance of survival was a stem cell transplant. Read the powerful @Newsweek article here. newsweek.com/diagnosed-with…

“Think of a chatbot as a research assistant rather than a decision-maker,” says MSK radiation oncologist @jjnaylor02. MSK experts share how to use #AI chatbots to get reliable information and emphasize the importance of confirming what patients learn with their care team. Learn more: bit.ly/4sNKgAR

MSK would like to welcome Steve Glass, our new Executive Vice President and Chief Financial Officer. Steve brings more than three decades of experience across the healthcare provider and payer sectors and will oversee MSK’s financial strategy and operations. At MSK, Steve will work closely with leadership across the institution to support the organization’s continued growth and mission to end cancer for life. Learn more about Steve: bit.ly/4bwOc22

I was honored to visit the @MSKCancerCenter Head and Neck Service, and to meet the outstanding faculty and fellows at such a storied program. Thank you especially to Dr. Rich Wong for the invitation, and to Dr. Shah and Dr. Shaha for sharing their wisdom and perspective.

INCREDIBLE leadership development meeting @MSKCancerCenter w/ @DrVickersMSK & Ami Schmitz featuring the great Dr. Francis Collin’s. Take 🏠pearls : 1) the best way to grow is to surround yourself by truth tellers . 2) you can still succeed with an unconventional path!

"We hope to convert advanced colorectal cancer into a manageable disease." #ICYMI: MSK physician-scientist @KarunaMDPhD and colleagues were awarded a @CancerGrand grant — a prestigious global initiative providing up to $25 million over five years to tackle some of the toughest problems in cancer research. Learn more: bit.ly/4d1GX4p

Congratulations to MSK's Dr. @AndreaCercek and Dr. Luis Diaz for being accepted into Round 3 of @statnews #STATMadness. Vote for their team now: bit.ly/3FfcuRu

🚨: Memorial Sloan Kettering Cancer Center security personnel identified a potential threat in the lobby at 1275 York Ave. and promptly notified the NYPD. The situation was quickly contained. No injuries were reported, and the NYPD has issued the all-clear. We are grateful for the swift response of our MSK security team and the NYPD.

With the flood of medical content readily available on our phones and other devices, how do you know what’s credible? It’s a growing challenge for patients and medical professionals alike. “Many people come across cancer misinformation when they are at a low point in their lives and looking for answers,” says Dr. David Miller, an MSK radiation oncology resident, who recently published a study on health misinformation. “If you have just received bad news from your doctor and you find something online that promises a better outcome, it’s natural that you’ll want to believe it.” If you’re searching for health information online, here are a few things to be aware of: bit.ly/3P3uUKc

Congratulations to Won Jun Kim, a student in the Tri-Institutional MD-PhD Program and training at @GSKGradSchool in the @AbdelWahablab, for being named one of the 12 recipients of the Harold M. Weintraub Graduate Student Award. This annual award recognizes outstanding achievement by graduate students in the biological sciences. Won Jun’s thesis focuses on mis-splicing-derived #neoantigens and cognate T-cell receptors in splicing factor mutant leukemias. Learn more: bit.ly/4czwMnN

RT @MSKCME: Calling all residents, fellows, and trainees: Hear from @KishKPatel on why the annual @MSKCancerCenter Symposium on #Lymphoma (…

Deeply honored to receive the @EUplatinum award for 2025’s most-cited paper. Immensely proud of my @UrologyMSK team and thankful to the patients who made this research meaningful—advancing how we think about #ProstateCancer surgery. @Uroweb @MSKCancerCenter

🧬 Precision oncology is reshaping treatment for stage IV colorectal cancer. @colontown Dr. Michael Foote @MikeFooteMD @MSKCancerCenter reviews how biomarkers—including RAS, BRAF, HER2, and MSI status—guide therapy selection, from EGFR inhibitors to targeted combinations and immunotherapy strategies. 🎥 Watch on #Vumedi: tinyurl.com/43p7nzwt #ColorectalCancer #GIOncology #PrecisionOncology #CancerResearch

@MikeMets5 Hi Mike, thank you for sharing this with us. If you'd like to discuss this further, please contact our Patient Representatives Department at 212-639-7202. They're here to make sure your rights are respected and your concerns are addressed. We hope this info is helpful.

Excited to announce a paper out today in @natgenet.nature.com identifying an approach to mitigate the risk of therapy-related myeloid malignancies in patients with cancer. Collaboration with @KellyLBolton @WashU and led by @IrenaeusChan & @PuZhang09980432 nature.com/articles/s4158…

@jjhernandeznyc Thank you so much for the kind words!

I have a message for everyone at @MSKCancerCenter, from the executives to the front desk- thank you for all your care. I’ve never been at a hospital, in New York City, whose staff have been more thoughtful and caring with their patients than the way you all have been. As a caregiver, I want to make sure you are aware of this. Please, never stray away or lose this touch. We are all grateful for your care.

Congratulations to MSK's most recent awards and appointments, including Dr. Luis Díaz for receiving the 2026 @GustaveRoussy Award, Dr. Cardinale Smith for being named among “252 Chief Medical Officers to Know” by @BeckersHR, Dr. Miguel-Angel Perales for being inducted into the 2026 class of fellows of the @ASTCT, and more: bit.ly/40YlPot

Just out in @NatureGenet: Research led by Dr. Omar Abdel-Wahab of MSK and Dr. Kelly Bolton of WashU Medicine offers a new method to prevent the development of chemotherapy-induced leukemia — one of the most lethal complications of cancer therapy for solid tumors. nature.com/articles/s4158…

Memorial Sloan Kettering Cancer Center (MSK) would like to welcome Dr. Lonny Yarmus, Head of the the Division of Subspecialty Medicine in the @MSK_DeptOfMed. A physician-scientist and internationally recognized leader in interventional pulmonology and procedural innovation, Dr. Yarmus is widely known for his expertise in minimally invasive diagnostics and therapeutics, outcomes research, and multidisciplinary program development. Learn more about Dr. Yarmus: bit.ly/4bibuIT